13.95CAD+1.38%Mkt Cap: 159.56M CADP/E: 17.88Last update: 2026-05-26
BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the…
Industry Peers
Drug Manufacturers - Specialty & Generic155.29BSEKP/E 172.0
58.11BTRYP/E 27.8
56.52BEURP/E 22.3
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BSEKP/E 40.0
Indicators:|
Key Statistics
Company
Market Cap159.56M CAD
Enterprise Value138.21M CAD
Revenue (TTM)43.05M CAD
Gross Profit32.96M CAD
Net Income (TTM)9.01M CAD
Revenue/Share3.823 CAD
Last Price13.95 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)17.88
P/E (Forward)24.73
PEG—
EV/EBITDA11.62
EV/Revenue3.21
P/S3.68
P/B3.76
EPS (TTM)0.78
EPS (Forward)0.56
52W Range
10.6564% of range15.80
52W High15.80 CAD
52W Low10.65 CAD
Profitability
Gross Margin76.57%
Oper. Margin23.00%
EBITDA Margin27.63%
Profit Margin20.93%
ROE21.73%
ROA18.23%
Growth
Revenue Growth9.90%
Earnings Growth25.50%
Cash Flow & Leverage
Operating CF9.01M CAD
CapEx (TTM)389.81K CAD
FCF Margin17.06%
FCF Yield4.60%
Net Debt-27.81M CAD
Net Debt/EBITDA-2.34
Balance Sheet
Debt/Equity0.02
Current Ratio5.51
Quick Ratio4.59
Book Value/Sh3.681 CAD
Cash/Share2.492 CAD
Dividends
Fwd Div Rate0.2200 CAD
Trail. Div Rate0.0000 CAD
Div. Yield1.52%
5Y Avg Yield—
Payout Ratio25.54%
Ex-Div DateMay 29, 2026
Pay DateMar 13, 2026
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)16.50 CAD
Target Range16.50 CAD – 16.50 CAD
# Analysts1
Ownership
Shares Out.11.44M
Float9.28M
Insiders34.62%
Institutions4.03%
Short Interest
Short Ratio0.3d
Short % Out.0.01%
Shares Short192
Short (prev mo.)1.58K
Technical
SMA 5014.81 (-5.8%)
SMA 20012.95 (+7.7%)
Beta0.64
S&P 52W Chg28.31%
Avg Vol (30d)6.39K
Avg Vol (10d)7.51K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—